Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjuvant Treatment in Cancer Patients with Neoantigen-primed DC Vaccine : a Single-arm, Open-label, Prospective Clinical Trial

NCT04147078 is registered in ClinicalTrials.gov with Sichuan University as lead sponsor.

NCT NCT04147078
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04147078 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjuvant Treatment in Cancer Patients with Neoantigen-primed DC Vaccine : a Single-arm, Open-label, Prospective Clinical Trial
Lead sponsor
Sichuan University
Phase
Phase 1
Overall status
Recruiting
Start date
June 1, 2019
Completion date
June 1, 2026
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colon rectal cancer, gastric cancer, hepatocellular carcinoma, non-small-cell lung cancer